ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The efficacy and safety of Sanqi Qushi Granule in patients with idiopathic membranous nephropathy --protocol of a multicenter, randomized control trial (SQ-AUTUMN)

Li, Chuang; Shan, Wenjun; Liang, Xing; Zhang, Qinghua; Qin, Xindong; Jiang, Sha; Hong, Xiaofan; Wang, Lijuan; Li, Ping; Gu, Haowen; Wang, Yi; Bao, Kun*广东省人民医院; 广州中医药大学
BMC Complementary Medicine and Therapies2023-4-27DOI: 10.1186/s12906-023-03950-9
6阅读
引用收藏
分享

摘要

Background Adult nephropathy is mainly caused by idiopathic membranous nephropathy (IMN). In cases of proteinuria, Modified Ponticelli Regimens (MPR) are often successful. However, it can cause adverse side effects. Oral Sanqi Qushi Granule (SQG) with MPR is effective in patients with IMN. However, whether it can improve the remission rate of IMN and shorten the remission time is unknown. In this trial, SQG with MPR on IMN will be evaluated clinically for its efficacy and safety.Methods We will randomly assign IMN patients who meet the criteria to receives SQG plus cyclical Cyclophosphamide (CTX)/steroids or with placebo plus cyclical CTX/steroids for 6 months. A 12-month follow-up will be conducted on them. Status of remission will be used to assess treatment efficacy.Discussio nThis study aims to appraise whether treatment with SQG plus cyclical CTX/steroids is superior to placebo plus cyclical CTX/steroids in the remission rate of patients with adult IMN. Adverse events of SQG plus MPR will be also evaluated for further researches about Chinese Medicine and MPR on whether it can improve the remission rate of IMN in half a year and shorten the remission time and relieve adverse effects will also be clarified.

学科与关键词

关键词
Sanqi Qushi GranuleModified Ponticelli RegimenCyclophosphamideSteroidIdiopathic membranous nephropathyRandomized controlled trial
相关
加载中…
  • Real-World Effects of Chinese Herbal Medicine for Idiopathic Membranous Nephropathy (REACH-MN): Protocol of a Registry-Based Cohort Study
    Yang, Lihong; Chen, Xueyin; Li, Chuang; Xu, Peng; Mao, Wei; Liang, Xing; Zuo, Qi; Ma, Weizhong; Guo, Xinfeng*; Bao, Kun*Frontiers in Pharmacology, 2022, 12: 760482.被引 2
  • Astragalus membranaceus formula for moderate-high risk idiopathic membranous nephropathy: A meta-analysis
    Wang, Dan; Wang, Lijuan; Zhang, Mingrui; Li, Ping; Zhang, Qinghua; Bao, Kun*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(9).
  • 不同治疗方案对特发性膜性肾病疗效的临床对照研究
    罗曼宇; 刘丽华; 刘声茂; 张冬梅临床肾脏病杂志, 2019, (11): 798-802.
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC Complementary Medicine and Therapies
发表日期
2023-04-27
卷期
第 23 卷, 第 1 期
页码
134
DOI
10.1186/s12906-023-03950-9
成果收录
SCIE
资助标注
Special Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ36, SZ2021ZZ09]; National Natural Science Foundation of China [81974565]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Natural Science Foundation of Guangdong Province [2022A1515011628]; Guangzhou Science and Technology Plan Project [202102010212]

作者

  • L

    Li, Chuang (第一作者)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • S

    Shan, Wenjun

    2 · guangzhou univ chinese med

查看全部 12 位作者收起作者
  • L

    Liang, Xing

    guangdong prov hosp

  • Z

    Zhang, Qinghua

    guangdong prov hosp

  • Q

    Qin, Xindong

    guangdong prov hosp

  • J

    Jiang, Sha

    guangdong prov hosp

  • H

    Hong, Xiaofan

    guangdong prov hosp

  • W

    Wang, Lijuan

    2 · guangzhou univ chinese med

  • L

    Li, Ping

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • G

    Gu, Haowen

    2 · guangzhou univ chinese med

  • W

    Wang, Yi

    2 · guangzhou univ chinese med

  • B

    Bao, Kun (通讯)

    guangdong prov hosp · 2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417